Ascenta Therapeutics' Series C Round

Ascenta Therapeutics raised a round of funding on April 09, 2007.

Ascenta Therapeutics is a privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. Ascenta's current focus is a portfolio …

Articles about Ascenta Therapeutics' Series C Round: